Clinical Trials

Clinical Trials for KZR-616

KZR-616 is currently being evaluated in Phase 2 clinical trials for the treatment of lupus nephritis and dermatomyositis/polymyositis.

Find out how KZR-616 works to harmonize the immune system.

Click here to learn more about what a clinical trial is and how it works. To learn more about participating in our clinical trials, please email clinicaltrials@kezarbio.com

A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus with and without Nephritis

Recruiting

A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus with and without Nephritis

Video: Top 5 Things to Know about KZR-616 for the Treatment of LN

More Information
A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients with Active Polymyositis or Dermatomyositis

Recruiting

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients with Active Polymyositis or Dermatomyositis

Video: What You Need to Know about KZR-616 for the Treatment of PM & DM

More Information